Literature DB >> 6659994

Paf-acether (platelet-activating factor) increases microvascular permeability and affects endothelium-granulocyte interaction in microvascular beds.

J Björk, L Lindbom, B Gerdin, G Smedegård, K E Arfors, J Benveniste.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6659994     DOI: 10.1111/j.1748-1716.1983.tb07343.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


× No keyword cloud information.
  17 in total

1.  Effects of PAF and PAF antagonists on the shape of venous endothelial cells in vitro.

Authors:  A M Northover
Journal:  Agents Actions       Date:  1989-08

2.  Effects of platelet-activating factor on vascular permeability and granulocyte recruitment in the rat trachea.

Authors:  J J Brokaw; D M Prow; C M Kirsch; G W White
Journal:  Lung       Date:  1991       Impact factor: 2.584

Review 3.  Platelet-activating factor and granulocyte-mediated oxidative stress. Strategy for in vivo oxyradical visualization.

Authors:  M Suematsu; M Tsuchiya
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart.

Authors:  G L Stahl; D J Lefer; A M Lefer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

5.  Effect of platelet-activating factor on leukocyte adhesion to microvascular endothelium. Time course and dose-response relationships.

Authors:  P K Dillon; M F Fitzpatrick; A B Ritter; W N Durán
Journal:  Inflammation       Date:  1988-12       Impact factor: 4.092

6.  Gastric mucosal damage induced by local intra-arterial administration of Paf in the rat.

Authors:  J V Esplugues; B J Whittle
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

7.  Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells.

Authors:  M Bunting; D E Lorant; A E Bryant; G A Zimmerman; T M McIntyre; D L Stevens; S M Prescott
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

8.  TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.

Authors:  P Canale; F Squadrito; D Altavilla; M Ioculano; B Zingarelli; G M Campo; G Urna; A Sardella; G Squadrito; A P Caputi
Journal:  Agents Actions       Date:  1994-10

9.  Endothelin 1 and prostacyclin attenuate increases in hydraulic permeability caused by platelet-activating factor in rats.

Authors:  Elizabeth L Cureton; Terry J Chong; Rita O Kwan; Kristopher C Dozier; Javid Sadjadi; Brian Curran; Gregory P Victorino
Journal:  Shock       Date:  2010-06       Impact factor: 3.454

10.  Platelet-activating factor (PAF) and the development of chronic subdural haematoma.

Authors:  Y Hirasima; S Endo; R Kato; T Ohmori; T Nagahori; M Nishijima; K Karasawa; S Nojima; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.